FDA Proposes Priorities For Cosmetic Ingredient Review: Mica, Probiotics, CBD

摘要

L ike many industry stakeholders, FDA clearly has cannabidiol (CBD) on its brain in the wake of the US farm bill’s passage late last year, which cleared barriers to wider marketing of industrial hemp-based consumer products. Under the Agriculture Improvement Act signed into law by President Donald Trump in December 2018, hemp is defned as the same cannabis plant that constitutes marijuana under the Controlled Substances Act, but with no more than 0.3% tetrahy- drocannabinol (THC).